Navigation Links
George Butler Joins Bionovo's Board of Directors
Date:3/13/2008

EMERYVILLE, Calif., March 13 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) announced today the appointment of George Butler, Ph.D., to the company's Board of Directors. Dr. Butler has extensive regulatory experience with pharmaceutical and biotech companies, and in particular in advancing cancer drug development and women's health.

"We are very excited to have George on board as we move into a new phase of the regulatory process with our advancing clinical trial programs," said Isaac Cohen, O.M.D., Bionovo's Chairman and CEO. He added, "George led the development of hormonal drugs for breast cancer as prior head of global regulatory affairs at Astra Zeneca, making him a perfect fit with our platform at Bionovo in women's health and cancer."

Dr. Butler says, "I believe the exciting pipeline of Bionovo will attract the interest of large Pharma in deals for the individual compounds or perhaps a larger deal for the entire oncology pipeline. What is truly special about Bionovo is their excellent batting average for bringing drugs through pre-clinical to clinical phase, which is almost unheard of in the industry."

Dr. Butler has 30 years of experience primarily in drug development and regulatory affairs in large pharmaceutical companies in the US and Europe. He has been one of the leaders driving improvement in the development and regulatory environment, and in speeding up the regulatory process at both the FDA and EMEA. His professional experience includes leadership roles at AstraZeneca and Novartis, where he headed the global Regulatory Affairs group. He has a long track record across several therapeutic areas of successful regulatory approvals. He has also played a leading role in discussions between the pharma
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
2. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
3. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
4. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
5. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
6. Royea Joins Eklin Medical Systems as VP of Worldwide Sales
7. Eric K. Rowinsky Joins ADVENTRX Board of Directors
8. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
9. Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
10. Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG
11. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...nk of it as origami very high-tech origami. , Re...oped a technique for fabricating three-dimensional...films by coupling photolithography and a self-fold...he films, only a few microns thick, offer mechanic...ieces of the same material. , "This is a complete...
(Date:11/23/2009)...imensional carbon layer in which the carbon atoms ...honeycomb. Carbon nanotubes are rolled-up sheets o...m graphite. Graphene boasts some very special char...cellent thermal conductor, and reconciles such con...n addition, graphene is impermeable to gases, whic...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
... Amnis Corporation announced today the,release of ...ding the,Commercial release of a multilaser capabi...dramatically extending the depth of field well bey...ser upgrade provides the customer with the flexibi...05nm (violet) laser and a 658nm,(red) laser. These...
...., Aug. 23 Nektar,Therapeutics (Nasdaq: NKTR ) t...Senior Vice President and CFO. Harkness reports to...l serve as an integral member of the company,s,new...of healthcare and finance, Tim is a,critical addit... "He brings,significant experience in both financi...
...ia, Aug. 23 , Highlights -- Revenue increased 28...illion -- Excluding one-off items EBITDA increase...6 million -- Excluding one-off items NPAT increas....5 million from A$2.0 million -- Reported NPAT gr...r comparable period including one-off items -...
Other Biology Technology:Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 2Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer 3Ellex FY2007 Year End Results 2Ellex FY2007 Year End Results 3
(Date:11/25/2009)...st as vital to your health as what you eat, found ...tudies. Their experiments in mice revealed that th... the liverthe body,s metabolic clearinghouseis mos...s circadian clock as conventional wisdom had it. ...large number of genes completely independent of th...
(Date:11/24/2009)...oday named 12 new grant recipients for 2009. The a... work across a broad spectrum of lupus research. A...d potential to drive scientific discovery to ultim... of systemic lupus. , The 2009 grants go to both...nation and include interdisciplinary and highly pr...
(Date:11/24/2009)...in that may help gut bacteria bind to the gastroin...otic producers to identify strains that are likely...eed to interact with cells lining the gut to have ...s in the gut they are more likely to stick around ...alie Juge from the Institute of Food Research. IF...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2One Shot May Someday Replace Six for Rabies 58126 1One Shot May Someday Replace Six for Rabies 58126 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 1University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 2University of Hawaii Maui Community College Selects American TeleCare for Allied Health Department 26apos 3Bs Nursing Telehealth Project 58122 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 1Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 2Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 3Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 4Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 5Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression Free Survival in Patients With Advanced Breast Cancer in P 58118 6
...available in French . , A novel x-ray technique... time scale never reached before has been develope...Scherrer Institute (PSI) in Switzerland. Results o...d of EPFL,s laboratory of Ultrafast Spectroscopy i... online December 11 in the journal Science . , T...
...a turtle,s first swim is the most critical of its ...ators to make it to the sea, the tiny voyager must...its bid for freedom. For youngsters hatching on th...gh: as many as 30% perish as they head for safe de...rough the waves cost the intrepid hatchlings? Curi...
...uma National Park, the last stronghold for the sav...ow hover at about 1,000 animals, down from an esti...ic weapons have decimated elephant populations pa...f the park., Civil unrest in has made conservatio...rds have been shot and killed in recent years. Ho...
Other Biology News:Molecules in the spotlight 2Cost of hatchling turtles' dash for freedom 2Missing: 2,000 elephants 2
...ulti-casting chamber is used for handcasting and v...ndcast (8.3 x 7.3 cm) or precast (8.6 x 6.8 cm) ge...udes an electrophoresis tank with built-in cooling...rculator (not included), lid with power cables, 6 ...
Protease Inhibitor Cocktail Set I from Calbiochem
...gnificantly increase the shelf life of diluted per...at room temperature storage conditions in addition...0.2 micron filtration, and contains no mercury or ... levels of activity for both the enzyme and the an...
NucleoSpin Extract II from MACHEREY-NAGEL
Biology Products: